Metastatic Hormone-Sensitive Prostate Cancer: Data From ARASENS and ARANOTE
A panel of medical oncologist reflect on clinical data from the ARASENS and ARANOTE trials utilizing combination strategies with darolutamide in mHSPC.
Key Updates Metastatic Prostate Cancer Treatment Hormone Sensitive Prostate Cancer Data From Prostate Cancer Metastatic Hormone Sensitive Prostate Cancer
Source: onclive.com